Venus Remedies Ltd

Venus Remedies Ltd

Venus Remedies Ltd has secured five marketing authorisations across four key international markets, including Kazakhstan, Peru, Kuwait, and Argentina, expanding its international presence and access to its pharmaceutical portfolio.

Venus Remedies Ltd

Venus Remedies Ltd has announced a special window for re-lodgement of transfer requests of physical shares, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Venus Remedies Ltd

Venus Remedies Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 26/10/2026 to consider and approve unaudited Standalone and Consolidated Financial Results for the period ended on 30th September 2026.

Venus Remedies Ltd

Venus Remedies Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of securities on stock exchanges.

Venus Remedies Ltd

Venus Remedies Ltd has informed about a change in its Corporate Identification Number (CIN) from L24232CH1989PLC009705 to L21002CH1989PLC009705, following the alteration of the object clause and adoption of amended Memorandum of Association.

Venus Remedies Ltd

Venus Remedies Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from October 1, 2026, till 48 hours from the declaration of the unaudited financial results for the period ending on September 30, 2026.

Venus Remedies Ltd

Venus Remedies Ltd held its 37th Annual General Meeting (AGM) through video conferencing on August 20, 2026. The meeting's business was transacted, and the voting results and scrutinizer's report are enclosed. All resolutions were passed with the requisite majority.

Venus Remedies Ltd

Venus Remedies Ltd has updated its Memorandum of Association to align with the Companies Act, 2013, and to reflect its current business practices and proposed business activities.

Venus Remedies Ltd

Venus Remedies Ltd held its 37th Annual General Meeting (AGM) on August 20, 2026, through video conferencing. The meeting's resolutions were passed with the required majority, as per the voting results. The company's secretary, Neha, has enclosed the voting results and the Scrutinizer's report, as per Section 108 of the Companies Act, 2013, and Rule 20(4) of the Companies (Management and Administration) Rules, 2014.

Venus Remedies Ltd

Venus Remedies Ltd has announced the appointment of new directors, including Mr. Saransh Chaudhary as Executive Director, Dr. Gurminder Singh Bedi as Non-Executive Independent Director, Dr. (Mrs.) Manu Chaudhary as Joint Managing Director, and Dr. (Mrs.) Savita Gupta as Non-Executive Independent Director.

Venus Remedies Ltd

Venus Remedies Ltd held its 37th Annual General Meeting on August 20, 2026, through video conferencing, where 59 members attended and passed three ordinary resolutions, including the adoption of audited financial statements and the declaration of a final dividend of Rs. 10.

Venus Remedies Ltd

Venus Remedies Ltd has published a notice on social media regarding a special window for re-lodgement of transfer requests of physical shares, as per SEBI regulations.

Venus Remedies Ltd

Venus Remedies Ltd has published a newspaper notice under Regulation 30 of the LODR regarding the publication of its 37th AGM notice. The notice is a routine procedural filing and does not contain any material information.

Venus Remedies Ltd

Venus Remedies Ltd has announced its annual report for FY 2025-26, along with the notice of its 37th Annual General Meeting scheduled for August 20, 2026. The meeting will consider various resolutions, including the re-appointment of directors, dividend declaration, and cost auditor remuneration.

Venus Remedies Ltd

Venus Remedies Ltd has announced its annual report for FY 2025-26, along with the notice for its 17th Annual General Meeting (AGM) scheduled on June 24, 2026. The report includes audited financial statements, dividend declaration, and the appointment of statutory auditors. The AGM will also consider the reappointment of an independent director and the appointment of a new joint statutory auditor.

Venus Remedies Ltd

Venus Remedies Ltd has announced its 37th Annual General Meeting (AGM) scheduled for August 20, 2026, through video conferencing. The AGM will consider the audited standalone and consolidated financial statements for FY 2025-26, re-appointment of directors, and other business. The company has also declared a final dividend of Rs. 10 per equity share.

Venus Remedies Ltd

Venus Remedies Ltd has announced its unaudited financial results for the period ended on 30.06.2026, which are to be published in a newspaper.